Viewing Study NCT02065193



Ignite Creation Date: 2024-05-06 @ 2:31 AM
Last Modification Date: 2024-10-26 @ 11:19 AM
Study NCT ID: NCT02065193
Status: UNKNOWN
Last Update Posted: 2014-02-17
First Post: 2014-02-12

Brief Title: Prevalence of Autism Spectrum Conditions in Mainland China
Sponsor: University of Cambridge
Organization: University of Cambridge

Study Overview

Official Title: Social Communication Research and Epidemiological Study in China
Status: UNKNOWN
Status Verified Date: 2014-02
Last Known Status: RECRUITING
Delayed Posting: No
If Stopped, Why?: Not Stopped
Has Expanded Access: False
If Expanded Access, NCT#: N/A
Has Expanded Access, NCT# Status: N/A
Acronym: China SCORE
Brief Summary: The China SCORE study is a prevalence study of Autism Spectrum Conditions ASC in 14 regions in mainland China It will include the following steps

1 Large population-based screening This study will be conducted in urban areas but not rural areas across mainland China One city of each region will participate and in total there will be 14 cities for screening Within each city a number of 40 to 60 ordinary primary schools will be randomly selected from the defined region All the students who are in 1st to 4th grade will asked to participate in order to form a sample of approximately 20000 students

Screening questionnaires The screening pack includes the Chinese CAST the AQ-Child the AQ-Adult short version 10 items and risk factors questionnaire An information sheet and consent form will be included in the pack as well
2 Further assessments We expect approximately 5 on the CAST will score positive in ordinary school population Thus for a 20000 sample we would expect 900 positives 90 response rate All the screen-positives and a random selected 5 from borderline group will be invited for clinical assessment The diagnosis of clinical assessment will be divided into three categories definite ASC suspected ASC and non-ASC Then all the children with clinical assessment results as definite ASC and suspected ASC and a randomly selected 10-20 non-ASC will be invited for research diagnostic assessment using the ADOS and ADI-R as well as RPM as IQ test After that the consensus diagnosis between ADOSADI-R assessment and the clinical diagnosis will be the final diagnosis
3 Case identification in special schools All the children in special schools or training institutes in study region will be asked to fill in the screening pack The children who do not attend any ordinary or special schools will be identified according to their residential ID in the studied regions All screen-positives in special education will be assessed using the ADOS and ADI-R Then those who met the criteria of ASC on ADOS orand ADI-R will be assessed by psychiatrists and the clinical diagnosis will be the final diagnosis

If we combine the prevalence of ordinary schools and special schools together we will get an estimate of the prevalence of ASC in school-population in China If we combine all the cases identified from schools and from residential records we will generate an estimate of the prevalence of ASC in the general population in mainland China
Detailed Description: None

Study Oversight

Has Oversight DMC: None
Is a FDA Regulated Drug?: None
Is a FDA Regulated Device?: None
Is an Unapproved Device?: None
Is a PPSD?: None
Is a US Export?: None
Is an FDA AA801 Violation?: None